Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2012
05/23/2012CN101899086B Saturated fatty chain acid Glu-Asp-Gly tripeptide amide, synthetic method and application thereof
05/23/2012CN101679485B Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
05/23/2012CN101608203B Fish skin collagen peptide with moistening effect and preparation process and application thereof
05/23/2012CN101407539B Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use
05/22/2012US8183343 Methods for treating a skin wound
05/22/2012US8183342 Method of treating chemotherapy-induced thrombocytopenia
05/22/2012US8183231 Substituted propane phosphinic acid derivatives
05/22/2012US8183212 Compound having GPR54 agonistic activity
05/22/2012US8183204 Methods and compositions for increasing skin remodeling
05/18/2012WO2012062977A1 Dermatopontin-activating peptides and cosmetic compositions including same
05/18/2012WO2012062777A1 CYCLIC RGD PEPTIDES OF AMINO ACIDS BASED ON THIAZOLES OR OXAZOLES AS SELECTIVE ANTAGONISTS OF THE ALFA ανβ3 INTEGRIN
05/17/2012US20120122799 Cyclic peptide antitumor agents
05/17/2012US20120122793 S-Protected Cysteine Analogs and Related Compounds
05/17/2012US20120122177 Viral Infection Enhancing Peptide
05/17/2012US20120122153 Acid-clevable linkers exhibiting altered rates of acid hydrolysis
05/17/2012US20120122135 Novel Peptidase Substrates
05/17/2012US20120121659 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121658 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121624 Hepatitis c virus ns3 protease inhibitors
05/17/2012US20120121574 Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore
05/16/2012EP2002259B1 Disheveled PDZ modulators
05/16/2012CN102459310A Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
05/16/2012CN102459309A Bleaching peptide hydrolysate proteasome activator and compositions containing same
05/16/2012CN102458436A Melanocortin receptor-specific peptides
05/16/2012CN102453078A New process for preparing trandolapril
05/16/2012CN102453077A Novel fluoronosiheptide and preparation method and application thereof
05/15/2012US8178520 Macrocyclic compounds as antiviral agents
05/15/2012US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
05/15/2012CA2638854C Pcr hot start by magnesium sequestration
05/10/2012WO2012061408A2 Method for making macrocycles
05/10/2012WO2012061113A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
05/10/2012WO2012061082A2 Chromobacterium bioactive compositions and metabolites
05/10/2012US20120116027 Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
05/10/2012US20120115774 Antimicrobial cationic lipo-beta-peptides
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114682 Peptides for binding fibrinogen and fibrin
05/10/2012CA2816681A1 Cytotoxic agents comprising new ansamitocin derivatives
05/10/2012CA2815789A1 Chromobacterium bioactive compositions and metabolites
05/09/2012EP2450365A1 T-cell death-inducing epitopes
05/09/2012EP2448923A1 Smac mimetic
05/09/2012EP1368064B1 Synthesis of tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
05/09/2012CN102443048A Synthetic method of 5-membered cyclopeptide
05/09/2012CN101735305B Synthesizing method of L-carnosine
05/09/2012CN101296937B Asymmetric synthesis of peptides
05/08/2012US8173774 Polypeptides and use thereof
05/08/2012US8173770 Intermediates for LHRH antagonist synthesis, process for the production, and process for LHRH antagonist production
05/08/2012US8173768 Peptides having antimicrobial and neurotrophic activity and uses thereof
05/08/2012US8173767 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
05/08/2012US8173605 Kokumi-imparting agent
05/08/2012US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm
05/08/2012CA2475097C Anti-inflammatory peptides
05/03/2012WO2012056205A1 Peptide
05/03/2012WO2012056157A1 Peptide compound useful for inhibiting amyloid plaque formation
05/03/2012WO2012055905A1 Process for the manufacture of degarelix and its intermediates
05/03/2012WO2012055903A1 Process for the manufacture of degarelix and its intermediates
05/03/2012WO2012055509A1 Diketopiperazine forming dipeptidyl linker
05/03/2012US20120108520 Antimicrobial Compounds and Formulations
05/03/2012US20120108499 Peptoid compounds
05/03/2012US20120108494 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
05/03/2012US20120107869 Organic compounds
05/03/2012US20120107800 Cell-targeting nanoparticles and uses thereof
05/03/2012US20120107324 TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOF
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
05/03/2012CA2856153A1 Peptide
05/03/2012CA2816175A1 Diketopiperazine forming dipeptidyl linker
05/03/2012CA2815270A1 Process for the manufacture of degarelix and its intermediates
05/03/2012CA2808196A1 Peptide compound useful for inhibiting amyloid plaque formation
05/02/2012EP2447276A1 Process for the manufacture of Degarelix and its intermediates
05/02/2012EP1678200B1 A method of modulating cell survival, differentiation and/or synaptic plasticity
05/02/2012EP1415992B1 Diamine derivatives
05/02/2012CN102439027A Peptide hydrolysate proteasome activators and compositions containing same
05/02/2012CN102432670A Silkworm chrysalis protein source dipeptide SS and application thereof
05/02/2012CN101775066B Method for synthesizing neotame
05/01/2012US8168623 Prodrugs of GABA analogs, compositions and uses thereof
05/01/2012US8168585 Purification of peptides from colostrum
05/01/2012CA2706525C Novel immunoregulatory peptides, compositions, and uses thereof
04/2012
04/26/2012WO2012054874A1 Novel macrocyclic inhibitors of hepatitis c virus replication
04/26/2012WO2011163398A3 Biomimetic peptides for bone augmentation
04/26/2012WO2011089396A3 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen
04/26/2012US20120101050 Compounds for enzyme inhibition
04/26/2012US20120101048 Compounds for enzyme inhibition
04/26/2012US20120101044 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
04/26/2012US20120101032 Novel macrocyclic inhibitors of hepatitis c virus replication
04/26/2012US20120101031 Macrocyclic hepatitis c serine protease inhibitors
04/26/2012US20120101026 Compounds For Enzyme Inhibition
04/26/2012US20120101025 Compounds For Enzyme Inhibition
04/26/2012US20120100562 Methods and compositions for modulating the wnt pathway
04/26/2012US20120100236 Chromobacterium bioactive compositions and metabolites
04/26/2012US20120100205 Components for producing amphoteric liposomes
04/25/2012EP2444414A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
04/25/2012EP2444411A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
04/25/2012EP2443136A1 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
04/25/2012EP2442832A1 Compositions and methods for treatment of multiple sclerosis
04/25/2012CN102428095A 新型蛋白酶体激活性抗衰老肽及含有所述肽的组合物 Novel protease-activating anti-aging peptides and compositions containing the peptides
04/25/2012CN102428075A Crystalline tripeptide epoxy ketone protease inhibitors
04/24/2012US8163890 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
04/24/2012US8163701 Prodrugs of active agents
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2414609C Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 307